GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (BOM:543245) » Definitions » Price-to-Tangible-Book

Gland Pharma (BOM:543245) Price-to-Tangible-Book : 3.42 (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Price-to-Tangible-Book?

As of today (2024-12-13), Gland Pharma's share price is ₹1748.20. Gland Pharma's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was ₹511.24. Hence, Gland Pharma's Price to Tangible Book Ratio of today is 3.42.

The historical rank and industry rank for Gland Pharma's Price-to-Tangible-Book or its related term are showing as below:

BOM:543245' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.63   Med: 4.07   Max: 9.28
Current: 3.42

During the past 7 years, Gland Pharma's highest Price to Tangible Book Ratio was 9.28. The lowest was 2.63. And the median was 4.07.

BOM:543245's Price-to-Tangible-Book is ranked worse than
64.37% of 842 companies
in the Drug Manufacturers industry
Industry Median: 2.425 vs BOM:543245: 3.42

A closely related ratio is called PB Ratio. As of today, Gland Pharma's share price is ₹1748.20. Gland Pharma's Book Value per Sharefor the quarter that ended in Sep. 2024 was ₹533.41. Hence, Gland Pharma's P/B Ratio of today is 3.28.


Gland Pharma Price-to-Tangible-Book Historical Data

The historical data trend for Gland Pharma's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Price-to-Tangible-Book Chart

Gland Pharma Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Tangible-Book
Get a 7-Day Free Trial - 6.87 7.52 2.63 3.62

Gland Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.58 - 3.62 - 3.51

Competitive Comparison of Gland Pharma's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Gland Pharma's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gland Pharma's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Gland Pharma's Price-to-Tangible-Book falls into.



Gland Pharma Price-to-Tangible-Book Calculation

Gland Pharma's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=1748.20/511.24
=3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Gland Pharma Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Gland Pharma Business Description

Traded in Other Exchanges
Address
Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307
Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. The group is also involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma Headlines

No Headlines